ended6월 7일· 1 sources
American Biomedical Leadership Erosion: The High Cost of Flawed Policy
미국 Biomedical Research의 위기: 잘못된 정책이 초래한 혁신 생태계의 붕괴
Why it matters
This analysis highlights the systemic dismantling of the US biomedical research sector caused by inaccurate political discourse and hasty regulatory changes. It emphasizes that without a return to evidence-based governance, the nation risks losing its competitive edge in global healthcare technology and life-saving innovation.
1
Sources
+0
24h
—
Growth
105d
Active
Biomedical ResearchUS Research PolicyScientific InfrastructureInnovation CrisisEvidence-based Policy